Trial Profile
Advanced PET-CT Directed Post-Prostatectomy Radiotherapy to Enhance Prostate Cancer Outcomes
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2024
Price :
$35
*
At a glance
- Drugs Fluciclovine 18F (Primary) ; Gallium (68Ga) gozetotide
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- 15 Mar 2023 Status changed from recruiting to active, no longer recruiting.
- 10 May 2019 Status changed from not yet recruiting to recruiting.
- 09 May 2019 Planned initiation date changed from 1 Apr 2019 to 15 May 2019.